
Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

An investment and advisory firm for the life science industry, run by experienced operating executives

Novalis LifeSciences is the direct investment arm of Novalis Capital Partners, a boutique firm founded in 2017 by Marijn E. Dekkers. Its team is made up of executives who have run life science businesses, and it funds and advises founders in that field.
The funds target life science tools, diagnostics and biopharma therapeutics. Named past holdings include Cerevel Therapeutics, Quanterix, Decipher Biosciences, Celsee and Ginkgo Bioworks.
Summary written by TrustList from the business's own published information, Sep 2026.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Novalis LifeSciences.
Similar listings buyers compare against this one.

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Product discovery software for B2B and B2C sellers, covering search, guided selling and product content

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Global venture capital firm and accelerator backing early-stage technology founders, formerly called 500 Startups

Venture capital fund backing early-stage technology startups with strong ties to Greece

Investment firm holding defence, aerospace and security technology businesses

Tokyo venture capital firm backing seed, early and later stage technology startups in Japan and abroad

Singapore mentoring and education platform guiding students on career and study choices
Everything here links back to the same verified catalogue. Pick your next stop.